BioLaunch
Accelerating Commercialization and Manufacturing of Biotechnology Solutions
While biotech R&D growth in Indiana has outpaced the nation since 2018, there are gaps in the state's innovation ecosystem that have caused the region to lag in biotech commercialization and entrepreneurship. The lack of regional pilot and commercial scale biomanufacturing infrastructure reflects national barriers. This results in intellectual property (IP) either sitting on the shelf or moving overseas to available, cheaper biomanufacturing capacity. BioLaunch directly addresses this through BioStart and BioCAN, catalyzing biotech innovation, supporting new and existing companies in Indiana and beyond, and accelerating the US production of innovative bioproducts. By formalizing a network of navigation resources, mentorship opportunities, and non-dilutive grant funding, BioLaunch will accelerate innovation, development, and commercialization of biotech and biomanufacturing solutions.
BioStart
BioStart will provide biotech startups the critical, specialized support needed along the development and commercialization pathway.
→ Provide
cross-functional mentoring and support for startups and founders in biotechnology and biomanufacturing
→ Strengthen accelerated pathways for IP commercialization
→ Connect innovators to other ARI-supported programs (DARPA, Innovation Voucher Grants, SBIR/STTR)
BioCAN (BioResource Coordination and Access Network)
BioCAN will connect the region's strong contract development and manufacturing organizations (CDMOs) with US innovators. To address the gap between domestic manufacturing needs and adequate funding, BioCAN will provide grants to help innovators access these resources by:
→ Coordinating the Lab/CDMO network
→ Growing the network
→ Directing innovators to network resources
→ Awarding funds to support network utilization